Add to ORKGThe Myopia Outcome Study of Atropine Treatment in Children (MOSAIC) is an investigator-led, double-masked randomised controlled trial of nightly atropine 0.01% eye drops compared to nightly placebo eye drops. A previously published protocol paper outlines the rationale, objective and sample size calculation for the study.1 A total of 250 participants were enrolled in the study and were randomised 2:1 to active treatment and placebo, respectively. This document outlines the plan for analysis of the 24-month outcomes of the MOSAIC
Myopia is a dynamic and rapidly moving field, with ongoing research providing a better understanding...
Background Myopia is a common visual disorder with increasing prevalence among developed countries ...
Myopia is a condition of enormous public health concern, affecting up to 2.5 billion people worldwid...
The Myopia Outcome Study of Atropine Treatment in Children (MOSAIC) is an investigator-led, double-m...
Purpose The Myopia Outcome Study of Atropine in Children (MOSAIC) aims to explore the efficacy, safe...
Purpose The Myopia Outcome Study of Atropine in Children (MOSAIC) aims to explore the efficacy, safe...
Purpose The Myopia Outcome Study of Atropine in Children (MOSAIC) aims to explore the efficacy, safe...
Background/aims: To report the protocol of a trial designed to evaluate the efficacy, safety and mec...
The Myopia Outcome Study of Atropine in Children (MOSAIC) is an investigator-led, double-masked, ran...
Background/aims To report the protocol of a trial designed to evaluate the efficacy, safety and mech...
Background/aims To report the protocol of a trial designed to evaluate the efficacy, safety and mech...
The evidence-basis based on existing myopia control trials along with the supporting academic litera...
Purpose: To evaluate the effect of a dual treatment modality for myopia, by improving accommodative ...
The effect of randomised controlled trials (RCTs) is diminished by inconsistent outcome reporting, p...
Myopia is a dynamic and rapidly moving field, with ongoing research providing a better understanding...
Background Myopia is a common visual disorder with increasing prevalence among developed countries ...
Myopia is a condition of enormous public health concern, affecting up to 2.5 billion people worldwid...
The Myopia Outcome Study of Atropine Treatment in Children (MOSAIC) is an investigator-led, double-m...
Purpose The Myopia Outcome Study of Atropine in Children (MOSAIC) aims to explore the efficacy, safe...
Purpose The Myopia Outcome Study of Atropine in Children (MOSAIC) aims to explore the efficacy, safe...
Purpose The Myopia Outcome Study of Atropine in Children (MOSAIC) aims to explore the efficacy, safe...
Background/aims: To report the protocol of a trial designed to evaluate the efficacy, safety and mec...
The Myopia Outcome Study of Atropine in Children (MOSAIC) is an investigator-led, double-masked, ran...
Background/aims To report the protocol of a trial designed to evaluate the efficacy, safety and mech...
Background/aims To report the protocol of a trial designed to evaluate the efficacy, safety and mech...
The evidence-basis based on existing myopia control trials along with the supporting academic litera...
Purpose: To evaluate the effect of a dual treatment modality for myopia, by improving accommodative ...
The effect of randomised controlled trials (RCTs) is diminished by inconsistent outcome reporting, p...
Myopia is a dynamic and rapidly moving field, with ongoing research providing a better understanding...
Background Myopia is a common visual disorder with increasing prevalence among developed countries ...
Myopia is a condition of enormous public health concern, affecting up to 2.5 billion people worldwid...